130 related articles for article (PubMed ID: 38497026)
1. Nanoparticle-Terpene Fusion: A Game-Changer in Combating Primary Amoebic Meningoencephalitis Caused by
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Omega; 2024 Mar; 9(10):11597-11607. PubMed ID: 38497026
[TBL] [Abstract][Full Text] [Related]
2. Natural Terpenes Inhibit the Cytopathogenicity of
Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
ACS Chem Neurosci; 2023 Dec; 14(23):4105-4114. PubMed ID: 37983556
[No Abstract] [Full Text] [Related]
3. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
4. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
[TBL] [Abstract][Full Text] [Related]
5. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
6. A Fluorometric Assay for the
Arberas-Jiménez I; Rizo-Liendo A; Sifaoui I; Chao-Pellicer J; Piñero JE; Lorenzo-Morales J
Microbiol Spectr; 2022 Aug; 10(4):e0051522. PubMed ID: 35862997
[TBL] [Abstract][Full Text] [Related]
7. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
[TBL] [Abstract][Full Text] [Related]
8. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
9. Kaempferol induces programmed cell death in Naegleria fowleri.
Lê HG; Kang JM; Võ TC; Na BK
Phytomedicine; 2023 Oct; 119():154994. PubMed ID: 37597363
[TBL] [Abstract][Full Text] [Related]
10. Antiamoebic Properties of Metabolites against
Siddiqui R; Boghossian A; Khatoon B; Kawish M; Alharbi AM; Shah MR; Alfahemi H; Khan NA
Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625183
[No Abstract] [Full Text] [Related]
11. Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
Siddiqui R; Mungroo MR; Anuar TS; Alharbi AM; Alfahemi H; Elmoselhi AB; Khan NA
Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740156
[TBL] [Abstract][Full Text] [Related]
12. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Siddiqui R
ACS Chem Neurosci; 2017 Dec; 8(12):2626-2630. PubMed ID: 29206032
[TBL] [Abstract][Full Text] [Related]
13. Imidazothiazole Derivatives Exhibited Potent Effects against Brain-Eating Amoebae.
Siddiqui R; El-Gamal MI; Boghossian A; Saeed BQ; Oh CH; Abdel-Maksoud MS; Alharbi AM; Alfahemi H; Khan NA
Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358170
[No Abstract] [Full Text] [Related]
14. Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment.
Chao-Pellicer J; Arberas-Jiménez I; Fuchs F; Sifaoui I; Piñero JE; Lorenzo-Morales J; Scheid P
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627700
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel marine oxasqualenoid yucatecone against Naegleria fowleri.
Arberas-Jiménez I; Cen-Pacheco F; Chao-Pellicer J; Sifaoui I; Rizo-Liendo A; Morales EQ; Daranas AH; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():61-71. PubMed ID: 37270868
[TBL] [Abstract][Full Text] [Related]
16. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
17. Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.
Akbar N; Kaman WE; Sarink M; Nazmi K; Bikker FJ; Khan NA; Siddiqui R
ACS Omega; 2022 Aug; 7(33):28797-28805. PubMed ID: 36033708
[No Abstract] [Full Text] [Related]
18. Studies on the cyst stage of Naegleria fowleri in vivo and in vitro.
Evdokiou A; Marciano-Cabral F; Jamerson M
J Eukaryot Microbiol; 2022 Mar; 69(2):e12881. PubMed ID: 34918439
[TBL] [Abstract][Full Text] [Related]
19. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
[No Abstract] [Full Text] [Related]
20. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
